A screen printed carbon electrode (SPCE) containing the electrocatalyst Meldola's Blue (MB) has been investigated as the base transducer for a reagentless glutamate biosensor. The biopolymer chitosan (CHIT) and multiwalled carbon nanotubes (MWCNTs) were used to encapsulate the enzyme glutamate dehydrogenase (GLDH) and the co-factor nicotinamide adenine dinucleotide (NAD + ).
Introduction
Glutamate is the principal excitatory neurotransmitter and a precursor for GABA, the primary inhibitory neurotransmitter. Deficiencies in the behaviour of neurological pathways that utilize glutamate and its receptors are associated with autism [1] , stroke [2] , Alzheimer's disease [3] , schizophrenia [4] and depression [5] . Glutamate is also a vital compound in cellular metabolism as it is associated with transamination, a key step in amino acid degradation, and is formed during deamination. Consequently the measurement of glutamate in biological fluids is of considerable interest. In addition, the widespread use of monosodium glutamate (MSG) in food products has led to increased interest in the use of new measurement methods for glutamate levels in food [6] .
In a previous paper we have reported on an approach to glutamate biosensor development, based on a screen-printed biosensor incorporating a redox mediator and glutamate dehydrogenase (GLDH). In that approach the required enzyme cofactor, nicotinamide adenine dinucleotide (NAD + ), was added into the analyte solution containing glutamate; the disposable biosensor was successfully applied to the analysis of serum and stock cubes [7] .
While successful, the main drawback of this approach for a commercial biosensor is the requirement to add the cofactor into the sample solution.
Carbon nanotubes (CNTs) are renowned for their unique electronic and mechanical properties [8] . They possess a high active surface area, excellent biocompatibility [9] and the ability to facilitate redox reactions with fast electron-transfer rates [10] . These abilities have popularised CNTs in the development of electrochemical biosensors.
Two forms of CNT exist; single walled CNT (SWCNTs) and multi-walled CNT (MWCNTs). SWCNTs possess a singular graphite sheet rolled into a tube to create a cylindrical nanostructure, whereas MWCNT consist of several shells of cylindrical tubes.
Integration of redox dyes such as Meldola's Blue (MB) into MWCNT matrices, has been previously demonstrated with well-defined voltammetric responses [11] - [13] . It should be mentioned that the electrocatalyst MB greatly reduces the over-potential for the oxidation of NADH [14] .
The low solubility of unmodified MWCNTs leads to poor homogenous dispersion, thus in the present study the MWCNTs were suspended in a solution containing chitosan (CHIT). CHIT is a natural polysaccharide derived from crustaceans, which enhances enzyme stability and possesses good film forming properties [15] , [16] . The dispersion of CNTs was possible due to the low pH required to solubilise the CHIT (pH < 3.0) [17] , which was achieved using
HCl. It was reported that the dispersion of MWCNTs in CHIT/HCl compared with other solvents gave the smallest particle sizes and resulted in the formation of a greater surface area without the need for functionalization.
It has previously been reported that NAD + was readily integrated into a glucose dehydrogenase biosensor and did not leach from the MWCNT matrix when coated onto the surface of a glassy carbon electrode [18] . This was achieved utilising a layer-by-layer assembly procedure. Other researchers have reported on the layer-by-layer immobilisation method using modified CNTs to immobilise glutamate oxidase [19] , [20] and horse radish peroxidase [21] . This procedure is regarded as a simple, inexpensive and highly versatile method for the incorporation of components into film structures [22] . The advantages of a reagentless device fabricated using this approach is that it leads to a low cost biosensor which is convenient to use as no additional cofactor is required to be added to the sample solution [23] , [24] .
This paper describes the steps involved in the layer-by-layer development of a fully reagentless amperometric biosensor for glutamate. The strategy employed to achieve this goal has involved the integration of the biological components (enzyme and cofactor) with multiwalled carbon nanotubes (MWCNTs) on the surface of a Meldola's Blue screen-printed carbon electrode (MB-SPCE). The biosensor has been applied to the determination of glutamate in serum sample and stock cubes.
Based on the literature, it is believed that this is the first report on the development and application of a reagentless amperometric glutamate biosensor, based on GLDH and NAD + integrated with a disposable screen-printed electrode.
Materials and Methods

Chemicals and reagents
All chemicals were of analytical grade, purchased from Sigma Aldrich, UK, except glutamate dehydrogenase (CAT: 10197734001) which was purchased from Roche, UK. 
Apparatus
All electrochemical experiments were conducted with a three-electrode system consisting of a carbon working electrode containing MB, (MB-SPCE, Gwent Electronic Materials Ltd; Ink Code: C2030519P5), a Ag/AgCl reference electrode (GEM Product Code C61003P7); both printed onto PVC, and a separate Pt counter electrode. The area of the working electrode was defined using insulating tape, into a 3 x 3 mm square area. The electrodes were then connected to the potentiostat using gold clips. Solutions, when required, were stirred using a circular magnetic stirring disk and stirrer (IKA® C-MAG HS IKAMAG, Germany) at a uniform rate. A µAutolab II electrochemical analyser with general purpose electrochemical software GPES 4.9 was used to acquire data and experimentally control the voltage applied to the SPCE in the 10 ml electrochemical cell which was used for hydrodynamic voltammetry.
An AMEL Model 466 polarographic analyser combined with a GOULD BS-271 chart recorder was used for all amperometric studies. Measurement and monitoring of the pH was conducted with a Fisherbrand Hydrus 400 pH meter (Orion Research Inc., USA). Sonications were performed with a Devon FS100 sonicator (Ultrasonics, Hove, Sussex, UK).
Principle of Operation of the Biosensor and Procedures
The overall principle of operation of the biosensor is shown in Fig 2 Fabrication was carried out using a layer-by-layer approach to produce a total of three layers.
Solutions were drop-coated onto the 3mm 2 carbon working electrode. Initial studies were performed to deduce the composition of layers 1 and 3. Figure 1 represents the layer-by-layer biosensor.
Layer 1 was formed by drop coating a 10µL mixture of MWCNTs suspended in a solution
containing 0.05% CHIT in a 0.05M HCl solution. This layer was allowed to partially dry at 4°C under vacuum for 10 minutes.
Layer 2 was optimised by carrying out amperometric studies with biosensors constructed using different mass combinations of CHIT, NAD + with a fixed GLDH content of 27U (Table 1 ). This layer was allowed to dry at 4°C under vacuum for 3 hours. 
Hydrodynamic Voltammetry
Hydrodynamic voltammetry was performed using the complete biosensor with 400 µM of glutamate, in 0.75 mM phosphate buffer (pH 7.0) containing 50mM NaCl , in order to enzymatically generate NADH so as to establish the optimum operating potential for the amperometric determination of glutamate in food and serum samples. An initial potential of -120mV was applied to the biosensor and the resulting steady state current was measured; the potential was then changed to -115mV and again a steady state current was measured. The procedure was continued by changing the potential by 50mV steps to a potential of +100mV, with subsequent steps increasing by 25mV up to a final potential of +150mV. The steady state currents were measured at each potential, then a hydrodynamic voltammogram was constructed by plotting the steady state currents against the corresponding potentials.
Optimisation studies with the proposed biosensor using amperometry in stirred solution.
All amperometric measurements were performed with stirred 10mL solutions of 75mM PB pH 7.0 with 50mM NaCl (PBS), using an applied potential of +0.1 V vs. Ag/AgCl. In order to optimise the conditions the biosensor was immersed in a stirred buffer solution, the potential applied and sufficient time was allowed for a steady-state current to be obtained.
The optimisation of each component in layer 2 was performed by measuring the amperometric response to the additions of glutamate over the concentration range of 7.5 µM to 100 µM glutamate. The variations in the quantities of the components are shown in Table   1 .
After the optimisation of the NAD + and CHIT components, the integration of additional 0.01M Meldola's Blue into each layer of the biosensor was investigated by amperometry.
Following optimisation of the individual biosensor components, studies into the effects of temperature and pH on the biosensor response were investigated. Optimum pH was determined by carrying out calibration studies over the pH range 5 -9. A separate study was conducted to determine the optimum temperature. The temperature was varied over the range 25 -40°C with the pH fixed at 7. The optimisation of the temperature and pH is displayed in the supplementary material (supplementary Fig 1 & Fig 2 respectively ). 
Application of optimised amperometric biosensor to the determination of glutamate in food.
An OXO cube was prepared by dissolving one cube in 50 mL of phosphate buffer and sonicating for 15 minutes. The endogenous concentration of MSG was determined by using the method of standard addition. An initial 5µl volume of the dissolved OXO cube was added to the stirred buffered solution (10 mL) in the voltammetric cell containing the biosensor, operated at +0.1 V (vs. Ag/AgCl) with subsequent standard additions of 3 µL of 25 mM glutamate.
The reproducibility of the biosensor assay for MSG analysis in OXO cubes was determined by repeating the whole procedure five times with five individual biosensors.
Application of optimised amperometric biosensor to the determination of glutamate in serum.
The endogenous glutamate concentration of serum was determined by injecting an initial volume of 150 µL of serum into 9.85mL of buffer solution. Amperometry in stirred solution using an applied potential of +0.1V vs. (Ag/AgCl) was conducted with the serum solution.
This was followed by additions of 3 µL aliquots of 25 mM standard glutamate solution to the voltammetric cell. The currents resulting from the enzymatic generation of NADH were used to construct standard addition plots, from which the endogenous concentration of glutamate was determined (n = 5). The reproducibility of the biosensor measurement was deduced by repeating the studies five times on a freshly diluted solution of the same serum with a fresh biosensor for each measurement.
The procedure was repeated using 50µL of serum spiked with 1.5 mM glutamate (n = 5) to determine to the recovery of the assay.
Due to the complex nature of the samples investigated, interferences such as ascorbic acid, sugars and other amino acids may be present. The possible effects of naturally occurring interferences from serum and OXO cubes were established using a dummy BSA biosensor. A dummy biosensor was constructed by drop coating the equivalent weight of the enzyme with BSA; however, no signals due to interfering substances were detected. 
Hydrodynamic Voltammetry
Hydrodynamic voltammetry was performed using the reagentless biosensor with 400 µM of glutamate in 0.75mM phosphate buffer (pH 7.0) containing 50mM NaCl. The optimum potential was considered to be +0.1V vs. Ag/AgCl (Fig 3) as this potential was situated on the plateau of the voltammetric wave. N/A Table 2 shows that the best performance for the glutamate biosensor was achieved with 106 µg NAD + and 10 µg of CHIT, together with 27U of GLDH in layer 2, in the absence of MB.
Optimisation Studies
It has been noted by [25] , that with increasing concentrations of CHIT, the particle size of untreated MWCNT's in aqueous solution is increased; consequently the larger particle size leads to increasingly entangled molecules of CNT/CHIT resulting in higher visocities. This change in visoscity would lead to a smaller diffusion coefficient, therefore leading to a decrease in the signal. This might explain why loadings of 15 and 20µg resulted in less sensitivity than 10µg in the present study. This also suggests that 5µg may not have sufficiently bound the biological components, in comparison to 10µg of CHIT. Consequently, a CHIT loading of 10µg was selected for further studies.
In order to asses the possibility of enchancing the effectiveness of the electron shuttling through the MWCNTs to the underlying MB electrode, the effect of adding additional MB into these layers was investigated. It was found that the sensitivity was increased from 0.315 nA/µM to 0.396 nA/µM and the linear range was unaltered. Consequently MB was incorporated into all layers of the biosensor for all further studies. Figure 5A shows a typical amperogram obtained with the optimised biosensor for different concentrations of glutamate. The inset (Fig 5B) shows the resulting calibration plots which are linear over the range 7.5 -105µM, the first calibration plot depicts Fig 5A; the detection limit was 3µM (based on n = 5, the coefficient of variation (CV) was 8.5%), based on three times the signal to noise, and the sensitivity was 0.39 nA/µM (based on n =5, the CV was 6.37%). It should be noted that the biosensor possesses sensitivity relative to surface area of 4.3µA/mM/cm 2 . This behaviour demonstrates the possibility of applying this device to food and biological samples.
Linear Range, Sensitivity, Detection Limit and Lifetime of Biosensor
The life time of the biosensor in continuous operation is 2 hours, whilst the shelf lifetime is at least 2 weeks without any change in sensitivity. For the latter study, biosensors were stored in a desiccator which was stored in a fridge at 4°C. It should be mentioned that biosensors based on the cofactor NAD + can be readily stabilised for over six months using commercially available enzyme stabilisers [26] . The life time of the biosensor was determined by calibration studies with known additions of glutamate in buffer (pH 7, 35°C). The sensitivity was then determined based on the slope of the subsequent calibration plots (n = 3).
Optimisation of Temperature and pH
The optimum pH was determined by carrying out calibration studies over the pH range 5 -9
at a temperature of 25°C. The optimum pH was determined to be pH 7 as biosensors achieved the greatest sensitivity at this pH. A neutral pH also ensures that further studies investigating food and serum will not require the pH to be changed to achieve maximum sensitivity, thereby reducing sample preparation steps. A separate study was conducted to determine the optimum temperature. The temperature was varied over the range 25 -40°C with the pH fixed at 7. The optimum temperature was determined to be 35°C.
Application of the optimum amperometric biosensor (MWCNT-CHIT-MB/GLDH-NAD-CHIT-MB/MWCNT-CHIT-MB) to the determination of glutamate in unspiked food.
Many food products are known to contain MSG as a flavour enhancer, therefore, we decided to apply our new reagentless biosensor to determine glutamate in a known brand of beef stock cube.
Standard addition was conducted by dissolving one OXO cube (5.9 g mass) in 50ml of PB and sonicating for 15 minutes until fully dissolved. Five replicate aliquots from this solution were analysed using fresh reagentless biosensors for each measurement. The determination was performed by adding an aliquot of PBS (9.95 mL) to the voltammetric cell, establishing a steady state current, and then injecting a 5µL volume of the OXO cube/PB solution into the cell. Sequential 3µL injections of 25 mM glutamate were then added to the cell, standard addition plots were constructed and from these the endogenous glutamate concentration was determined (n = 5). The mean quantity of glutamate recovered in unspiked OXO Cubes was 90.6 mg/g, with a CV of 7.52%; results are shown in Table 3 . A typical amperogram obtained from the analysis of an OXO cube utilising the reagentless biosensor is shown in Figure 3 in the supplementary material.
The average percentage of glutamate was calculated relative to the mass of an OXO cube and was found to be 18.1% (± 1.36%, n = 5). This compares favourably with a previously published value for MSG content in OXO cubes [7] . The quantity of glutamate recovered from the stock cube compares favourably with levels calculated with an optical biosensor, validated with HPLC [27] and utilising high performance thin layer chromatography [28] .
The optical biosensor and HPLC analysis determined an L-glutamate level of 18.29% (± 0.66%) and 17.70% (± 0.34%) based on n = 3, whilst the high performance thin layer chromatography technique determined a level of 133.50 mg/g (± 0.84%, n = 3). These values compare favourably to the values we have determined utilising the reagentless biosensor. Amperometry, in conjunction with standard addition, was used to determine the endogenous levels of glutamate and the recovery for serum spiked with additional glutamate. The replicate serum samples were analysed using a fresh biosensor for each measurement. A typical amperogram obtained from the analysis of unspiked serum utilising the reagentless biosensor is shown in Figure 4 in the supplementary material.
The data obtained on serum samples using the glutamate biosensor are shown in Table 3 . The mean endogenous level of glutamate detected was 1.44 mM for the unspiked samples. The coefficient of variation was 8.54% for the five individual samples. This value is comparable to our previous publication [7] in which we report a value of 1.68 mM. It is worth noting this also compares favourably to a value discovered by a bioluminescence method [29] .
The biosensors were then used to determine glutamate in spiked serum by fortifying with 1.50 mM of glutamate. The results are shown in Table 4 . The mean recovery (n = 5) was 104% with a CV of 2.91%. 
Conclusion
This paper has described the successful development of a reagentless amperometric glutamate biosensor. This was achieved by incorporating the biocomponents using a layerby-layer procedure involving chitosan and MWCNTs. The device produced well defined steady state currents over extended operating times indicating that the bio-components are securely immobilised onto the base transducer.
The reagentless glutamate biosensor, fabricated in this study, is to date the first of its kind; our biosensor detection limit compares favourably to those previously reported for nonreagentless glutamate sensors. The limit of detection of our biosensor is 3 µM, whereas detection limits of 3.8µM, 10µM, 300µM, 5µM, 5µM, 20µM, 28µM and 50µM were reported The device and its components have been fully optimised to produce a reproducible reagentless biosensor which has been applied to the analysis of glutamate in clinical and food samples. Notably, the samples required no pre-treatment, other than dilution. The content of glutamate determined in OXO cubes and in serum compares favourably to that determined with our previous glutamate biosensor [7] .
This novel layer-by-layer approach to biosensor fabrication may hold promise as a generic platform for future biosensors based on dehydrogenase systems.
It should be mentioned that the analysis of neuronal cells for changes in glutamate flux is of significant biomedical interest. High levels of glutamate leads to excitotoxicity, which is associated with diseases previously mentioned in the introduction. For potential future studies and applications, it is of value to consider how our biosensor compares to previously reported sensors which determine neuronal glutamate. Microelectrodes coated with glutamate dehydrogenase are uncommon; this is likely due to the requirement of integrating the cofactor NAD + onto the surface of the microelectrode without leeching, as mentioned previously. By miniaturizing our reagentless biosensor, the lower operating potential required to generate an analytical response would prove beneficial for the analysis of glutamate in real time, in neuronal cells. Our approach would negate the requirement for additional enzymes or use of charged membranes such as Nafion, to block out potential interferences. It should be feasible to incorporate the approach described in this paper into a implantable system by dip coating a carbon fibre electrode (10µM diameter) into formulation described in this paper. A schematic diagram displaying the layer-by-layer drop coating fabrication procedure used to construct the reagentless glutamate biosensor, based on a MB-SPCE electrode .  Fig 2. Schematic displaying the interaction between the immobilized enzyme GLDH and glutamate at the surface of the electrode and the subsequent generation of the analytical response.
Fig 3.
Hydrodynamic voltammograms obtained using MB-SPCE/MWCNT-CHIT-MB/GLDH-NAD + -CHIT-MB/MWCNT-CHIT-MB biosensor in the presence of 400µM glutamate in 75mM phosphate buffer (pH 7.0) containing 50 mM NaCl .  Fig 4. SEM imaging of each individual layer of the reagentless biosensor. The scale is the same for all SEM images. Fig 5. A) Amperogram conducted with the proposed final biosensor. Each arrow represents an injection of 3µL of 25mM glutamate in a 10mL stirred solution containing supporting electrolyte; 75mM, PB (pH 7.0), with 50mM NaCl at an applied potential of +0.1V vs. Ag/AgCl.
B)
Calibration plots of five individually tested biosensors. The amperogram is depicted in the first calibration plot. Figures   Fig 1. Temperature study conducted over the range of 25 to 40°C. Values represent average currents generated at 30µM (n = 3) .  Fig 2. pH study conducted over the range of pH 5 to 9. Values represent average currents generated at 15µM (n = 3).
Supplementary
Fig 3.
Amperogram displaying the response obtained for unspiked OXO cube followed by two additions of 7.5µM glutamate. 75mM, PB (pH 7.0), with 50mM NaCl at an applied potential of +0.1V vs. Ag/AgCl.
Fig 4.
Amperogram displaying the response obtained for unspiked serum followed by two additions of 7.5µM glutamate. 75mM, PB (pH 7.0), with 50mM NaCl at an applied potential of +0.1V vs. Ag/AgCl. 
